Echinacea purpureaand Melatonin Augment Natural-Killer Cells in Leukemic Mice and Prolong Life Span
- 1 June 2001
- journal article
- research article
- Published by Mary Ann Liebert Inc in The Journal of Alternative and Complementary Medicine
- Vol. 7 (3), 241-251
- https://doi.org/10.1089/107555301300328115
Abstract
Objective: We recently showed that daily dietary administration of Echinacea purpurea root extract to normal mice for as little as 1 week resulted in significant elevations of natural-killer (NK) cells (immune cells that are cytolytic to virus-containing cells and many tumor cells). Such boosting of this fundamental immune cell population suggests a prophylactic role for this herb in normal animals. Based on this evidence, our goal in the present work was to assess the role of dietary administration of this herbal extract to mice bearing leukemia, a type of tumor well known to be a target for NK cells. Design: A commercially available root extract of E. purpurea, which we have already shown to be highly effective in mice, was administered daily for 50 days from the onset of leukemia (day 0). Control leukemic mice received no extract. Other leukemic mice received the NK-enhancing neurohormone, melatonin, administered precisely as above. In all treatment and control categories, some mice were sampled at 9 days after tumor onset, others were sampled at 3 months, and still others were left to assess treatment effect on life span. Results: At 9 days (intermediate stage leukemia; death beginning by day 17-18), E. purpurea–treated mice had a 2.5-fold increase in the absolute numbers of NK cells in their spleens. By 3 months after leukemia onset, E. purpurea–treated mice still had 2–3 times the normal numbers of NK cells in their spleens. No leukemic, untreated (control) mice remained alive at 3 months, hence the comparison with normal animals. Moreover, at 3 months post-tumor onset, all the major hemopoietic and immune cell lineages in their bone marrow birth site, were recorded at normal numbers, in E. purpurea-consuming, leukemic mice. The survival advantage provided by administering these leukemic mice with E. purpurea was highly significant versus untreated, leukemic mice when analyzed by Kaplan-Meier survival statistics. Conclusion: The present study has provided the first systematic analysis, under controlled laboratory conditions, of the effect(s) of the botanical, E. purpurea, in vivo, in leukemic hosts. The profoundly positive effects of this herb in disease abatement observed in this study suggest the therapeutic potential of E. purpurea, at least with respect to leukemia, if not other tumors as well.Keywords
This publication has 45 references indexed in Scilit:
- In VitroInhibition of Cyclooxygenase and 5-Lipoxygenase by Alkamides fromEchinaceaandAchilleaSpeciesPlanta Medica, 1994
- Polysaccharides isolated from plant cell cultures of Echinacea purpurea enhance the resistance of immunosuppressed mice against systemic infections with Candida albicans and Listeria monocytogenesInternational Journal of Immunopharmacology, 1993
- Nonspecific Immunostimulation with Low Doses of Cyclophosphamide (LDCY), Thymostimulin, and Echinacea Purpurea Extracts (Echinacin) in Patients with Far Advanced Colorectal Cancers: Preliminary ResultsCancer Investigation, 1992
- Application of purified polysaccharides from cell cultures of the plant Echinacea purpurea to test subjects mediates activation of the phagocyte systemInternational Journal of Immunopharmacology, 1991
- In VitroInhibition of Arachidonate Metabolism by some Alkamides and Prenylated PhenolsPlanta Medica, 1989
- Phase 1 Clinical Trial of Recombinant Interleukin-2: A Comparison of Bolus and Continuous Intravenous InfusionCancer Investigation, 1989
- Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced CancerNew England Journal of Medicine, 1987
- Antitumor action of shiitake(Lentinus edodes) fruit bodies orally administered to mice.CHEMICAL & PHARMACEUTICAL BULLETIN, 1987
- DISPLAY OF THE NEUTRAL GLYCOLIPID GANGLIO-N-TETRAOSYLCERAMIDE (ASIALO GM1) ON CELLS OF THE NATURAL KILLER AND T LINEAGESTransplantation, 1982
- A glycolipid on the surface of mouse natural killer cellsEuropean Journal of Immunology, 1980